Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Cost of Revenue: 2009-2020

Historic Cost of Revenue for Avadel Pharmaceuticals (AVDL) over the last 10 years, with Jun 2020 value amounting to $3.3 million.

  • Avadel Pharmaceuticals' Cost of Revenue fell 9.30% to $3.3 million in Q2 2020 from the same period last year, while for Jun 2020 it was $11.0 million, marking a year-over-year decrease of 23.22%. This contributed to the annual value of $5.7 million for FY2020, which is 52.64% down from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Cost of Revenue stood at $3.3 million for Q2 2020, which was up 33.70% from $2.5 million recorded in Q1 2020.
  • Avadel Pharmaceuticals' 5-year Cost of Revenue high stood at $6.6 million for Q1 2018, and its period low was $2.4 million during Q4 2019.
  • For the 3-year period, Avadel Pharmaceuticals' Cost of Revenue averaged around $3.5 million, with its median value being $3.3 million (2019).
  • In the last 5 years, Avadel Pharmaceuticals' Cost of Revenue skyrocketed by 68.94% in 2018 and then crashed by 50.46% in 2019.
  • Avadel Pharmaceuticals' Cost of Revenue (Quarterly) stood at $2.6 million in 2016, then surged by 56.23% to $4.0 million in 2017, then climbed by 6.03% to $4.3 million in 2018, then tumbled by 43.76% to $2.4 million in 2019, then dropped by 9.30% to $3.3 million in 2020.
  • Its Cost of Revenue stands at $3.3 million for Q2 2020, versus $2.5 million for Q1 2020 and $2.4 million for Q4 2019.